CiRC Biosciences
Biotechnology ResearchIllinois, United States11-50 Employees
CiRC Biosciences is developing life-changing regenerative medicines, with an initial goal of restoring vision lost to degenerative retinal diseases.
Biotech Innovation CiRC Biosciences focuses on developing regenerative medicines, particularly for degenerative retinal diseases, presenting a niche market for advanced biotechnology solutions.
Funding Success With $7M in funding, CiRC Biosciences has financial stability to support research and development, paving the way for potential sales partnerships or technology licensing agreements.
Digital Presence Utilizing a tech stack including WordPress, Chart.js, and YouTube, CiRC Biosciences showcases a strong online presence that could attract collaborations or digital marketing opportunities.
Strategic Location Situated in Chicago, a hub for biotechnology and healthcare innovation, CiRC Biosciences is strategically positioned for networking with potential clients, investors, and collaborators in the industry.
Competitive Analysis Analyzing competitors like Transgene and Generex Biotechnology Corporation provides insights into market positioning, allowing CiRC Biosciences to tailor sales strategies for competitive advantage.
CiRC Biosciences uses 8 technology products and services including WordPress, Google Font API, Chart.js, and more. Explore CiRC Biosciences's tech stack below.
CiRC Biosciences Email Formats | Percentage |
FLast@circbiosciences.com | 46% |
First.Last@circbiosciences.com | 4% |
FLast@circbiosciences.com | 46% |
First.Last@circbiosciences.com | 4% |
Biotechnology ResearchIllinois, United States11-50 Employees
CiRC Biosciences is developing life-changing regenerative medicines, with an initial goal of restoring vision lost to degenerative retinal diseases.
CiRC Biosciences has raised a total of $7M of funding over 2 rounds. Their latest funding round was raised on May 01, 2024 in the amount of $7M.
CiRC Biosciences has raised a total of $7M of funding over 2 rounds. Their latest funding round was raised on May 01, 2024 in the amount of $7M.